The individual displayed no identified risk factors for immunocompromise, including but not limited to diabetes (random glucose: 104 mg/L), sarcoidosis, malignancy (CA199: 8.5U/mL; CEA: 1.5ng/mL; PSA: 1.117 ng/mL), solid organ transplant, or prolonged steroid usage. This evidence concerns the gene CEACAM5 and sarcoidosis.